Aurora Spine Corporation (ASG.V)
CAD 0.34
(-4.23%)
CAD 0.34
(-4.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.87 Million USD | 13.02% |
| 2022 | 2.54 Million USD | 421.2% |
| 2021 | -793.01 Thousand USD | -225.43% |
| 2020 | 632.22 Thousand USD | -67.87% |
| 2019 | 1.96 Million USD | 69.7% |
| 2018 | 1.15 Million USD | 9255.12% |
| 2017 | -12.66 Thousand USD | 93.43% |
| 2016 | -192.84 Thousand USD | 66.73% |
| 2015 | -579.63 Thousand USD | -120.48% |
| 2014 | -262.89 Thousand USD | 0.0% |
| 2012 | -158.16 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 3.29 Million USD | 14.54% |
| 2024 Q2 | 3.22 Million USD | -2.22% |
| 2024 Q3 | 1.78 Million USD | -12.57% |
| 2023 Q3 | 3.3 Million USD | -0.49% |
| 2023 Q4 | 2.87 Million USD | -12.83% |
| 2023 FY | 2.87 Million USD | 13.02% |
| 2023 Q1 | 2.57 Million USD | 0.9% |
| 2023 Q2 | 3.31 Million USD | 29.14% |
| 2022 Q2 | 1.96 Million USD | 113.66% |
| 2022 Q1 | 918.75 Thousand USD | 215.86% |
| 2022 FY | 2.54 Million USD | 421.2% |
| 2022 Q4 | 2.54 Million USD | 19.89% |
| 2022 Q3 | 2.12 Million USD | 8.24% |
| 2021 Q2 | 1.69 Million USD | 45.45% |
| 2021 Q4 | -793.01 Thousand USD | 40.49% |
| 2021 Q1 | 1.16 Million USD | 84.42% |
| 2021 FY | -793.01 Thousand USD | -225.43% |
| 2021 Q3 | -1.33 Million USD | -178.58% |
| 2020 Q2 | 435.71 Thousand USD | -50.14% |
| 2020 FY | 632.22 Thousand USD | -67.87% |
| 2020 Q4 | 632.22 Thousand USD | 145.57% |
| 2020 Q3 | 257.45 Thousand USD | -40.91% |
| 2020 Q1 | 873.85 Thousand USD | -55.59% |
| 2019 FY | 1.96 Million USD | 69.7% |
| 2019 Q1 | 1.7 Million USD | 47.44% |
| 2019 Q2 | 2.14 Million USD | 25.4% |
| 2019 Q3 | 2.08 Million USD | -2.6% |
| 2019 Q4 | 1.96 Million USD | -5.75% |
| 2018 FY | 1.15 Million USD | 9255.12% |
| 2018 Q4 | 1.15 Million USD | 286.75% |
| 2018 Q3 | -620.88 Thousand USD | -176.31% |
| 2018 Q1 | 1.41 Million USD | -25.32% |
| 2018 Q2 | -224.7 Thousand USD | -115.93% |
| 2017 FY | -12.66 Thousand USD | 93.43% |
| 2017 Q1 | -143.21 Thousand USD | 25.73% |
| 2017 Q4 | 1.88 Million USD | 1103.72% |
| 2017 Q3 | -188.23 Thousand USD | -74.53% |
| 2017 Q2 | -107.84 Thousand USD | 24.69% |
| 2016 Q2 | -117.67 Thousand USD | 72.65% |
| 2016 FY | -192.84 Thousand USD | 66.73% |
| 2016 Q4 | -192.84 Thousand USD | 74.23% |
| 2016 Q1 | -430.31 Thousand USD | 25.76% |
| 2016 Q3 | -748.22 Thousand USD | -535.84% |
| 2015 Q1 | -1.97 Million USD | -651.57% |
| 2015 Q3 | -297.95 Thousand USD | 65.7% |
| 2015 Q4 | -579.63 Thousand USD | -94.53% |
| 2015 FY | -579.63 Thousand USD | -120.48% |
| 2015 Q2 | -868.58 Thousand USD | 56.04% |
| 2014 Q1 | -7.78 Million USD | 0.0% |
| 2014 Q4 | -262.89 Thousand USD | 87.9% |
| 2014 Q3 | -2.17 Million USD | 60.56% |
| 2014 Q2 | -5.51 Million USD | 29.24% |
| 2014 FY | -262.89 Thousand USD | 0.0% |
| 2013 Q3 | -2.27 Million USD | 0.0% |
| 2012 FY | -158.16 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -18.17 Million CAD | 115.836% |
| Therma Bright Inc. | -91.84 Thousand CAD | 3234.523% |
| Theralase Technologies Inc. | 342.96 Thousand CAD | -739.424% |
| VentriPoint Diagnostics Ltd. | -1.01 Million CAD | 382.26% |